Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
4.56M
-
Number of holders
-
152
-
Total 13F shares, excl. options
-
125M
-
Shares change
-
-1.49M
-
Total reported value, excl. options
-
$931M
-
Value change
-
-$5.48M
-
Put/Call ratio
-
0.96
-
Number of buys
-
80
-
Number of sells
-
-69
-
Price
-
$7.47
Significant Holders of RECURSION PHARMACEUTICALS, INC. - Common Stock (RXRX) as of Q2 2023
184 filings reported holding RXRX - RECURSION PHARMACEUTICALS, INC. - Common Stock as of Q2 2023.
RECURSION PHARMACEUTICALS, INC. - Common Stock (RXRX) has 152 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 125M shares
.
Largest 10 shareholders include BAILLIE GIFFORD & CO (25.1M shares), BlackRock Inc. (11.6M shares), VANGUARD GROUP INC (11.3M shares), Kinnevik AB (publ) (10.4M shares), MIC Capital Management UK LLP (8.45M shares), Data Collective IV GP, LLC (5.94M shares), STATE STREET CORP (5.7M shares), ARK Investment Management LLC (4.74M shares), FMR LLC (4.56M shares), and Laurion Capital Management LP (3.18M shares).
This table shows the top 152 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.